3 terminated. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Terminated 3 |
| Phase 2 | 1 | Terminated 1 |
Follow Allogeneic Stem Cell Transplantation: new trials by email Literature Review of Allogeneic Stem Cell Transplantation trials Research Report on Allogeneic Stem Cell Transplantation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Siremadlin Alone and in Combination With Donor Lymphocyte Infusion in Acute Myeloid Leukemia Post-allogeneic Stem Cell Transplant Siremadlin - Acute Myeloid Leukemia, Allogeneic Stem Cell Transplantation | Phase 1 / Phase 2 | Terminated | Novartis Pharmaceuticals | 8 | 2023-02-23 | 2025-05-16 |
| Recombinant Human Growth Hormone (RH-GH) For Accelerating Immune Reconstitution Post Unrelated Cord Blood Transplant Genotropin (Recombinant Human Growth Hormone) - Allogeneic Stem Cell Transplantation | Phase 1 | Terminated | Mitchell Horwitz, MD | 14 | 2008-09-01 | 2014-03-20 |
| CMV pp65 Specific T Cell Adoptive Immunotherapy in Allogeneic Stem Cell Transplantation for Malignant Disease CMV pp65 Specific T Cells - Allogeneic Stem Cell Transplantation | Phase 1 | Terminated | H. Kim Lyerly | 2 | 2005-08-01 | 2012-11-12 |
Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Leukemia (1) · Leukemia, Myeloid (1) · Neoplasms (1) · Neoplasms by Histologic Type (1)
Growth Hormone (1) · Human Growth Hormone (1) · siremadlin (1)
H. Kim Lyerly (1) · Mitchell Horwitz, MD (1) · Novartis Pharmaceuticals (1)
United States (2) · Germany (1) · Italy (1) · Spain (1)
H. Kim Lyerly, M.D. (1) · Michael A Morse, M.D. (1) · Mitchell Horwitz, MD (1)